mark.| 3
Apr |
Break |
| 10
Apr
|
Chairperson:
Ariumi Main Discusser Group: A Pattaravadee Srikoon, D4 (Okada Project Laboratory) The significantly simultaneous activity of minor sub-population CD56dimCD16neg NK cells in innate immune system defending tumor and viral infection Takayuki Chikata, D3 (Takiguchi Project Laboratory) Introduction of my research at Oxford University in UK |
17
Apr |
Break |
| 24
Apr
|
Chairperson:
Ueno Special Seminar Jaclyn K. Mann (nee Wright), Ph.D. (University of KwaZulu-Natal, South Africa) Recent topics in HIV-1 fitness studies [Topic1] Validation of the predicted fitness landscape in and around multi-dimensionally conserved regions of HIV-1 Gag. [Topic2] Nef-mediated CD4 and HLA class I down-regulation activities differ among HIV-1 subtypes. |
| 1
May |
Chairperson:
Kuwata Main Discusser Group: B Hiroki Goto, D4 (Okada Project Laboratory) Targeting IL-6 in the treatment of AIDS Kristel Paola Ramirez Valdes, D3 (Matsushita Project Laboratory) Isolation of monoclonal antibodies against HIV-1 CRF01_AE |
8 May |
Break: AAI Immunology 2013 (3-7 May) |
15 May |
Break |
22
May
|
Chairperson:
Monde Main Discusser Group: C Hironori Hayashi, D4 (Hematology) The structures of the darunavir-resistant HIV-1 protease suggest how HIV-1 obtains the darunavir resistance MD Abu Osman, D2 (Suzu Project Laboratory) IL-32γ inhibits HIV-1 replication in macrophages, but its inhibitory effect is overcame by a stimulatory cytokine M-CSF |
| 29
May
|
Chairperson:
Sakai Special Seminar Yorifumi Satou, Associate Professor (Satou Project Laboratory) Regulatory mechanism of latent and persistent retroviral infection |